Has-mir-122 kit for early prediction of hepatocirrhosis developed from chronic hepatitis B and detection method thereof

A hsa-mir-122, detection method technology, applied in the field of medical biological detection, can solve problems such as not seen, and achieve the effect of simple preparation method, convenient use, and high detection accuracy

CN101555520AInactive Publication Date: 2009-10-14SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
0 Cites 7 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2009-10-14
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to the technical field of medical bio-detection and relates to a kit used for detecting the content of hsa-mir-122 in blood plasma or blood serum to early predict hepatocirrhosis developed from chronic hepatitis B and a detection method thereof. At present, there is not existed any effective method for predicting hepatocirrhosis developed from chronic hepatitis B, which brings inconvenience for early prediction and treatment clinically. By comparing health crowd with patients with chronic hepatitis B and comparing the contents of hsa-mir-122 in blood plasma between the patients with chronic hepatitis B in four different disease conditions, the invention finds that the change of the content of has-mir-122 can be used as a means of early prediction of the hepatocirrhosis developed from chronic hepatitis B. The invention provides a kit for detecting the hsa-mir-122 to predict hepatocirrhosis developed from chronic hepatitis B. The kit comprises reverse transcription primer, upstream and downstream primers of Real-time PCR and an amplification system and the like; by clinical trial, the accuracy rate of detection is up to about 85 percent, therefore, the kit can be used for early prediction of hepatocirrhosis developed from chronic hepatitis B.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of medical biological detection, and is a kit for detecting the content of hsa-mir-122 in plasma or serum to early predict the development of chronic hepatitis B into cirrhosis, and a detection method thereof. Background technique

[0002] Chronic hepatitis B is a chronic infectious disease caused by hepatitis B virus (HBV) infection, which can easily develop into liver cirrhosis and liver cancer. There are about 2 billion people in the world who have ever been infected with hepatitis B virus, and there are currently about 350 million chronic hepatitis B virus carriers, and 70% of them are in our Asian region.

[0003] Liver cirrhosis is a chronic disease characterized by diffuse fibrosis, pseudolobules and regenerative nodules in liver tissue, and is a serious outcome of chronic hepatitis B. If it can block, alleviate or even reverse the further progression of chronic hepatitis B Development can improve th...

Examples

Embodiment 1

[0039] Embodiment 1: prepare test kit of the present invention (for one person's use)

[0040] The kit of the present invention consists of the following:

[0041] 1. 1 tube of reverse transcription primer, 100 μl / tube Concentration: 10 μM The reverse transcription primer is:

[0042] GTCGTATCCAGTGCGAACTGTGGCGATCGGTACGGGCTACACTCGGCA

[0043] ATTGCACTGGATACGACCAAACA

[0044] 2. One tube of upstream and downstream primers for Real-time PCR, 100 μl / tube Concentration: 10 μM;

[0045] The upstream primer is: GCGTGGAGTGTGACAATGG

[0046] The downstream primer is: AGTGCGAACTGTGGCGAT

[0047] 3.Trizol reagent 1 tube 2000μl / tube

[0048] 4. Chloroform 1 tube 500μl / tube

[0049] 5. Absolute ethanol 1 tube 7ml / tube

[0050] 6. DEPC H 2 O 1 tube 1000μl / tube

[0051] 7. dd H 2 O 1 tube 2000μl / tube.

[0052] The present invention finds the mature body sequence UGGAGUGUGACAAUGGUGUUUG of hsa-mir-122 according to the known bioinformatics, and its specific reverse transcription prim...

Embodiment 2

[0065] Embodiment 2: the detection of kit of the present invention

[0066] 1. Collection of plasma samples and sample preparation:

[0067] Because plasma has the advantages of convenient sampling, non-invasiveness, and continuous detection, the detection of chronic hepatitis biomarkers from plasma can improve the prognosis of chronic hepatitis to cirrhosis to a new level, so as to achieve early prevention and early treatment the goal of.

[0068] Plasma samples were collected in the inpatient department of Shanghai Changhai Hospital: 25 cases of moderate chronic hepatitis B patients (male: 18 cases, female: 7 cases), 28 cases of chronic hepatitis B severe patients (male: 20 cases, female: 8 cases), 25 cases of hepatitis B combined Liver cirrhosis (compensated stage) patients (male: 21 females: 4 cases), 25 cases of hepatitis B combined liver cirrhosis (decompensated stage) patients (male: 15 females: 4 cases), healthy control group 10 healthy blood donations members (male:...

Embodiment 3

[0089] Example 3: Comparison of hsa-mir-122 content in peripheral blood plasma of healthy people

[0090] It has been reported in the literature that in the peripheral blood of healthy people, the miRNA content is very stable, and in terms of gender, the difference between men and women is very small (see literature: Chen X, Ba Y, Ma L, et al.Characterization ofmiRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18:997-1006). Before comparing the miRNA content in the patient's peripheral blood plasma, according to the same method as in Examples 1 and 2, a comparison was made to the amount of hsa-mir-122 in the plasma of healthy people, a total of 10 cases (male: 6 examples, female : 4 cases) (see figure 1 ). The results of Real-time PCR verified the statement in the literature that the miRNA content in the peripheral blood of healthy people remained basically stable.